Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-043263
Filing Date
2025-03-21
Accepted
2025-03-21 16:36:16
Documents
3
Period of Report
2025-03-21

Document Format Files

Seq Description Document Type Size
1 6-K nasdaq_notice_-_3-21-25.htm 6-K 27368
2 EX-99.1 imab-ex99_1.htm EX-99.1 14142
3 GRAPHIC img44095488_0.jpg GRAPHIC 33379
  Complete submission text file 0000950170-25-043263.txt   88663
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 25761055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)